Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Colorectal Cancer.”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01013805
What this trial is testing

Preoperative Radiotherapy and Chemotherapy in Patients With Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
Trans Tasman Radiation Oncology Group 41
Early research (Phase 1)Ended earlyNCT01271166
What this trial is testing

Glivec® Plus m-FOLFOX Avastin® in Advanced Colorectal Cancer

Who this might be right for
Advanced Colorectal Cancer
Novartis Pharmaceuticals 10
Early research (Phase 1)Study completedNCT00128622
What this trial is testing

Denileukin Diftitox Followed by Vaccine Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Breast CancerColorectal CancerLung Cancer+2 more
H. Kim Lyerly 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT04117945
What this trial is testing

Regorafenib, With Cetuximab or Panitumumab, for the Treatment of Unresectable, Locally Advanced, or Metastatic Colorectal Cancer

Who this might be right for
BRAF V600E NegativeKRAS Gene Mutation NegativeLocally Advanced Unresectable Colorectal Adenocarcinoma+10 more
Academic and Community Cancer Research United 22
Large-scale testing (Phase 3)Looking for participantsNCT05236972
What this trial is testing

PACE: PD-1 Antibody For dMMR/MSI-H Stage III Colorectal Cancer

Who this might be right for
Colorectal Carcinoma
Sun Yat-sen University 323
Not applicableUnknownNCT03602677
What this trial is testing

Indocyanine Green Fluorescence Imaging in Prevention of Colorectal Anastomotic Leakage

Who this might be right for
Colorectal CancerColorectal NeoplasmsGastrointestinal Cancer+3 more
Oulu University Hospital 1,062
Post-approval studies (Phase 4)UnknownNCT03127072
What this trial is testing

Study Comparing Radio Frequency Ablation Plus Chemotherapy and Chemotherapy Alone in Patients With Unresectable CRLM

Who this might be right for
Colorectal Cancer Liver Metastasis
Fudan University 200
Large-scale testing (Phase 3)UnknownNCT02031939
What this trial is testing

Randomized Controlled Study on Optimize Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer

Who this might be right for
Advanced Rectal Cancer
Sun Yat-sen University 556
Large-scale testing (Phase 3)Study completedNCT02284139
What this trial is testing

Pilot Trial of EGF Ointment for the Patients With EGFR-i Related Skin Side Effects

Who this might be right for
Non-small Cell Lung CancerPancreatic CancerColorectal Cancer
Dong-A University Hospital 90
Not applicableUnknownNCT04034953
What this trial is testing

Prevention of Obesity-related Cancers: Setting up of a Multi-Cancer Education and Prevention Program in Hong Kong

Who this might be right for
ObesityColorectal CancerProstate Cancer+1 more
Chinese University of Hong Kong 10,000
Early research (Phase 1)Looking for participantsNCT06654037
What this trial is testing

Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal Cancer

Who this might be right for
Metastatic Microsatellite Stable Colorectal CarcinomaRefractory Microsatellite Stable Colorectal CarcinomaStage IV Colorectal Cancer AJCC v8
National Cancer Institute (NCI) 39
Large-scale testing (Phase 3)Study completedNCT02394795
What this trial is testing

Panitumumab and RAS, Diagnostically-useful Gene Mutation for mCRC

Who this might be right for
Colorectal Cancer
Takeda 823
Testing effectiveness (Phase 2)UnknownNCT02161822
What this trial is testing

Capecitabine Plus Simvastatin in Locally Advanced Rectal Cancer Patients

Who this might be right for
Adenocarcinoma of Rectum
Samsung Medical Center 60
Not applicableStudy completedNCT06342622
What this trial is testing

Young-onset Colorectal Cancer Screening Based on Artificial Intelligence

Who this might be right for
Colorectal Cancer
Renmin Hospital of Wuhan University 11,000
Large-scale testing (Phase 3)UnknownNCT00958737
What this trial is testing

Combination Chemotherapy for 3 Months or 6 Months in Treating Patients With Stage III Colon Cancer

Who this might be right for
Colorectal Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 2,000
Early research (Phase 1)Study completedNCT00120939
What this trial is testing

Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer

Who this might be right for
Breast NeoplasmsOvarian NeoplasmsProstatic Neoplasms+2 more
Pharmacyclics LLC. 25
Testing effectiveness (Phase 2)Study completedNCT01105377
What this trial is testing

Azacitidine and Entinostat in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Recurrent Colon CancerRecurrent Rectal CancerStage IV Colon Cancer+1 more
National Cancer Institute (NCI) 47
Not applicableActive Not RecruitingNCT02394834
What this trial is testing

An Exploratory Study of Treatment Sensitivity and Prognostic Factors in a Efficacy and Safety Study of mFOLFOX6 + Bevacizumab Versus mFOLFOX6 + Panitumumab Therapy in Patients With Chemotherapy-naïve Unresectable Advanced or Recurrent Colorectal Cancer

Who this might be right for
Colorectal Cancer
Takeda 757
Not applicableLooking for participantsNCT06582914
What this trial is testing

Lynch Syndrome Integrative Epidemiology and Genetics

Who this might be right for
Lynch Syndrome
University of Colorado, Denver 5,000
Testing effectiveness (Phase 2)Study completedNCT00454116
What this trial is testing

A Phase II, Double Blind Study of 2 Doses of ZACTIMA™(ZD6474) in Combination With FOLFIRI vs FOLFIRI Alone for the Treatment of Colorectal Cancer in Patients

Who this might be right for
Colorectal Cancer
Genzyme, a Sanofi Company 106
Next Page